ANAPTYSBIO INC·4

Feb 11, 5:28 PM ET

Londei Marco 4

4 · ANAPTYSBIO INC · Filed Feb 11, 2019

Insider Transaction Report

Form 4
Period: 2019-02-08
Londei Marco
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-02-08+35,00035,000 total
    Exercise: $68.89Exp: 2029-02-07Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 8, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION